Table 4.

Reports of miR-200 in ovarian cancer

miRNA	Findings	Reference
200a/b/c	High expression in ovarian cancer samples	[7,8,10]
	High expression correlated with decreased progression-free survival	[8]
	Decreased in tumors with high β-tubulin III levels	[33]
200a	Increased in 43% of primary ovarian carcinomas, associated with high-grade and late-stage tumors	[9]
	High expression correlated with recurrence free survival and, or, overall survival	[34,35]
	Increased tumour growth, targets p38α and modulates oxidative stress signature	[34]
	Sensitized tumors to paclitaxel	[34]
200c	Targeted TUBB3 for degradation leading to increased paclitaxel sensitivity	[36]
	Low levels associated with incomplete response to paclitaxel–carboplatin chemotherapy and recurrence	[33]
	Decreased adhesion to basement membrane complex	[36]
	Repressed ZEB1, decreased migration and invasion in HEY cells	[36]